Ricardo E. Vilain

17.8k total citations
41 papers, 1.6k citations indexed

About

Ricardo E. Vilain is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ricardo E. Vilain has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Ricardo E. Vilain's work include Cancer Immunotherapy and Biomarkers (14 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (8 papers). Ricardo E. Vilain is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (8 papers). Ricardo E. Vilain collaborates with scholars based in Australia, United States and Brazil. Ricardo E. Vilain's co-authors include Richard A. Scolyer, John F. Thompson, James S. Wilmott, Georgina V. Long, Jason Madore, Jennifer H. Yearley, Hojabr Kakavand, Alexander M. Menzies, Richard Kefford and Peter Hersey and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ricardo E. Vilain

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo E. Vilain Australia 15 1.2k 504 452 281 207 41 1.6k
Chan-Young Ock South Korea 21 1.0k 0.9× 286 0.6× 508 1.1× 309 1.1× 272 1.3× 42 1.4k
Kelly Olino United States 23 1.5k 1.3× 499 1.0× 413 0.9× 470 1.7× 544 2.6× 75 2.2k
Andrew S. Brohl United States 22 1.2k 1.1× 346 0.7× 528 1.2× 426 1.5× 131 0.6× 100 2.0k
Stefan Dirnhofer Switzerland 22 539 0.5× 298 0.6× 377 0.8× 367 1.3× 230 1.1× 89 1.6k
Flora Poizat France 19 759 0.6× 161 0.3× 390 0.9× 149 0.5× 530 2.6× 77 1.2k
Quan Liao China 24 1.0k 0.9× 172 0.3× 358 0.8× 330 1.2× 659 3.2× 135 1.7k
Junko Ozao‐Choy United States 14 710 0.6× 693 1.4× 193 0.4× 237 0.8× 194 0.9× 48 1.3k
Lidia Gatto Italy 21 342 0.3× 115 0.2× 450 1.0× 326 1.2× 194 0.9× 83 1.2k
Jens Schreiner Germany 15 649 0.6× 535 1.1× 153 0.3× 204 0.7× 146 0.7× 22 1.2k
Jean-Marie Cuillerot United States 12 1.4k 1.2× 683 1.4× 511 1.1× 154 0.5× 152 0.7× 31 1.6k

Countries citing papers authored by Ricardo E. Vilain

Since Specialization
Citations

This map shows the geographic impact of Ricardo E. Vilain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo E. Vilain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo E. Vilain more than expected).

Fields of papers citing papers by Ricardo E. Vilain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo E. Vilain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo E. Vilain. The network helps show where Ricardo E. Vilain may publish in the future.

Co-authorship network of co-authors of Ricardo E. Vilain

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo E. Vilain. A scholar is included among the top collaborators of Ricardo E. Vilain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo E. Vilain. Ricardo E. Vilain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westhuizen, André van der, Megan Lyle, Moira C. Graves, et al.. (2022). Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge. Cancer Research Communications. 2(8). 814–826. 3 indexed citations
2.
Vilain, Ricardo E., Simon J. King, James Lynam, et al.. (2021). Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme. Biomarker Insights. 16. 3399279855–3399279855. 4 indexed citations
3.
Vilain, Ricardo E., Richard A. Scolyer, Serigne Lo, et al.. (2021). Confocal microscopy, dermoscopy, and histopathology features of atypical intraepidermal melanocytic proliferations associated with evolution to melanoma in situ. International Journal of Dermatology. 61(2). 167–174. 6 indexed citations
4.
Graves, Moira C., et al.. (2019). Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles. Frontiers in Medicine. 6. 113–113. 17 indexed citations
5.
Lo, Serigne, Ricardo E. Vilain, James S. Wilmott, et al.. (2019). The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study. Journal of the American Academy of Dermatology. 82(4). 910–919. 8 indexed citations
6.
Scurry, James, Geoffrey Otton, Kenneth Jaaback, et al.. (2018). Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer. Gynecologic Oncology. 151(2). 306–310. 12 indexed citations
7.
Vilain, Ricardo E., Alexander M. Menzies, James S. Wilmott, et al.. (2017). Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. Clinical Cancer Research. 23(17). 5024–5033. 191 indexed citations
8.
Madore, Jason, Dario Strbenac, Ricardo E. Vilain, et al.. (2016). PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma. Clinical Cancer Research. 22(15). 3915–3923. 92 indexed citations
10.
Vilain, Ricardo E., Stanley W. McCarthy, & Richard A. Scolyer. (2016). The regenerating naevus. Pathology. 48(2). 108–112. 8 indexed citations
11.
Busam, Klaus J., Ricardo E. Vilain, Trina Lum, et al.. (2016). Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation. The American Journal of Surgical Pathology. 40(6). 786–795. 39 indexed citations
12.
Kakavand, Hojabr, James S. Wilmott, Alexander M. Menzies, et al.. (2015). PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients. Clinical Cancer Research. 21(14). 3140–3148. 115 indexed citations
13.
Wang, Shu, James S. Wilmott, Jason Madore, et al.. (2015). Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases. Annals of Surgical Oncology. 22(9). 2972–2977. 9 indexed citations
14.
Wilmott, James S., Matthew A. Field, Peter A. Johansson, et al.. (2015). Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes. Pathology. 47(7). 683–693. 6 indexed citations
15.
Luk, Peter P., et al.. (2015). Punch biopsy of melanoma causing tumour cell implantation: Another peril of utilising partial biopsies for melanocytic tumours. Australasian Journal of Dermatology. 56(3). 227–231. 1 indexed citations
16.
Kakavand, Hojabr, Ricardo E. Vilain, James S. Wilmott, et al.. (2015). Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases. Modern Pathology. 28(12). 1535–1544. 73 indexed citations
17.
Ko, Jennifer S., Víctor G. Prieto, Paul Elson, et al.. (2015). Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients. Modern Pathology. 29(2). 122–130. 20 indexed citations
18.
Madore, Jason, Ricardo E. Vilain, Alexander M. Menzies, et al.. (2014). PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PDL 1 clinical trials. Pigment Cell & Melanoma Research. 28(3). 245–253. 333 indexed citations
19.
Dwight, Trisha, Diana E. Benn, Adele Clarkson, et al.. (2012). Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology. 37(2). 226–233. 85 indexed citations
20.
Gill, Anthony J., Angela Chou, Ricardo E. Vilain, et al.. (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. The American Journal of Surgical Pathology. 34(5). 636–644. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026